Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Novo invests US$ 1.2 bn in new rare disease plant in Denmark; FDA approves two drugs for atopic dermatitis

As the year draws to a close, the US Food and Drug Administration (FDA) has been approving drugs at a feverish pace. It approve...

Impressions : 657

Lilly, Amgen inject billions into manufacturing; GSK's Blenrep bests world's top-selling myeloma drug

In Phispers this week, Eli Lilly announced an investment of US$ 3 billion towards building a new plant in Wisconsin (US) to me...

Impressions : 10032

Novartis snaps up PTC's Huntington's disease program in US$ 2.9 bn deal; Sanofi to set up insulin facility in China

In Phispers this week, we bring you news of how political changes in the US could impact the pharma industry. Big Pharma has r...

Impressions : 715

Sarepta inks US$ 11 bn RNA deal with Arrowhead; Roche expands CAR-T arsenal; Novartis buys Kate for US$ 1 bn

The week saw three large deals signed in promising fields. First, Sarepta Therapeutics signed a US$ 11.4 billion deal with Ar...

Impressions : 1120

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Novo invests US$ 1.2 bn in new rare disease plant in Denmark; FDA approves two drugs for atopic dermatitis

Lilly, Amgen inject billions into manufacturing; GSK's Blenrep bests world's top-selling myeloma drug

Novartis snaps up PTC's Huntington's disease program in US$ 2.9 bn deal; Sanofi to set up insulin facility in China

Sarepta inks US$ 11 bn RNA deal with Arrowhead; Roche expands CAR-T arsenal; Novartis buys Kate for US$ 1 bn

BeiGene's Biologic Tevimbra Receives Approval in US

Genzyme's Biologic Lumizyme Receives Suppl Approval in US

Rubicon's Generics Bumetanide Receives Approval in US

BMS's Biologic Opdivo Qvantig Receives Approval in US

Aurobindo's Generics Deutetrabenazine Receives Approval in US

Ridgeback's Biologic Ebanga Receives Suppl Approval in US

Novo Nordisk's Biologic Alhemo Receives Approval in US

Genzyme's Biologic Cerezyme Receives Suppl Approval in US

Hikma's Generics Phytonadione Receives Approval in US

Amgen's Biologic Kanjinti Receives Suppl Approval in US

Bhargava Phytolab Receives FDA Warning Letter

Enforcement Report - Week of December 25, 2024

Brands International Receives FDA Warning Letter

Astellas Issues Voluntary Nationwide Recall of Prograf

Akron Formulations Receives FDA Warning Letter

Viatris Receives FDA Warning Letter

Sombra Cosmetics Receives FDA Warning Letter

Alcon Lab Issues Voluntary Nationwide Recall of Systane

FDA Issues Form 483 to Biotika AS

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee

Strides Pharma Science Ltd leads gainers in 'A' group

Galera Therapeutics completes acquisition of Nova Pharmaceuticals

CDSCO flags two drugs as spurious, another 111 listed as NSQ

Flagship biotech Valo Health ends 2024 with mid-stage fail

BeiGene's Tevimbra approved in US for first-line gastric cancer

Sangamo shares plunge after Pfizer ends hemophilia A therapy deal

Drugmakers to raise US prices on over 250 medicines starting Jan 1

Merck wins UK approval for lung disease drug acquired in $11 B deal

Private equity interest shows potential of healthcare sector

Erring Drug Companies Face Stricter Actions from Today

Kwality Pharma gains on securing SAHPRA approval for Tamoxifen

Zydus gets USFDA nod for generic topical anaesthetic cream

Breckenridge Receives FDA Approval for Methadone HCl Injection

Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL

bioAffinity Technologies Hosts Live Investor Webinar on December 19

Pharma lobby, govt meet to discuss OTC drug regulation

Sandoz Resolves US Generic Drug Antitrust Litigation

Granules India gets USFDA nod for ADHD Treatment

Glenmark Pharma arm launches seizure drug in US

Gland Pharma Gets FDA Approval For Phytonadione Injectable

Flagship biotech Valo Health ends 2024 with mid-stage fail

BeiGene's Tevimbra approved in US for first-line gastric cancer

Sangamo shares plunge after Pfizer ends hemophilia A therapy deal

Altamira Successfully Delivers Circular RNA via Nanoparticles

IDEAYA snags second ADC in tie-up with Hengrui worth $1B

Takeda Announces Approval of HYQVIA in Japan

Sterling & Zydus agree to extend completion of business transfer

Mankind Pharma inks pact with Innovent for immunotherapy drug

Exicure Partners with GPCR Therapeutics to Fuel Growth in Biotech

OS Therapy Partner with B2i Digital for Biotech Invest Engagement

Supriya opens new API block at Lote Parshuram site in Maharashtra

Alembic Pharma Panelav unit clears Brazil GMP audit

HPAPI for Drug Development and Delivery

Smallcap Pharma Stock Soars 10% On High Demand API Filing

Power of AI & Machine Learn to Revolutionize API Production

Leading the Way in Tetracycline APIs

How to Choose the Right CDMO Partner: Key Factors to Consider

TAPI Rebrands To Symbolize Innovative Future And Strategic Vision

N-Zyme & LGM Pharma Create Novel Pepsin Inhibitor Therapy

Wanbury Q2 FY25 revenue at Rs. 161.2 crore, up 11.6%

CDSCO flags two drugs as spurious, another 111 listed as NSQ

FDA recall of Systane eye drops due to fungal contamination

Chemists selling spurious meds may face prosecution

FDA restricts imports of some Viatris drugs made at India facility

AbbVie Healthcare under government lens for 'violations'

Fagron Provides FDA Update on Wichita Inspection

Lexicon Receives Complete Response Letter for Zynquista

FDA ups Boston Scientific cryoablation recall tied to 4 deaths

Auro Pharma's Telangana unit gets 2 USFDA observations

FDA warns online vendors selling unapproved weight-loss drugs

Oncotelic Therapeutics Implements PDAOAI Platform

Spectral AI Guides Retail Investors on Exercising Warrants

Stem Health Revolutionizes Skin Regeneration with Stem Cell Tech